These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 4346497)
21. [The drug treatment of renal tuberculosis]. Gartmann JC Schweiz Med Wochenschr; 1967 Jul; 97(30):976-9. PubMed ID: 4298882 [No Abstract] [Full Text] [Related]
22. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics. Zierski M Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863 [No Abstract] [Full Text] [Related]
23. New antituberculosis drugs and concepts of prophylaxis. Wolinsky E Med Clin North Am; 1974 May; 58(3):697-704. PubMed ID: 4362723 [No Abstract] [Full Text] [Related]
25. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium]. Marion L Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451 [No Abstract] [Full Text] [Related]
26. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. Grunert M; Reutgen H; Iwainsky H Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136 [No Abstract] [Full Text] [Related]
27. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis]. Iaschenko BP Probl Tuberk; 1967; 45(9):21-6. PubMed ID: 4303748 [No Abstract] [Full Text] [Related]
28. Drugs for tuberculosis. Br Med J; 1968 Sep; 3(5619):664-7. PubMed ID: 4175142 [No Abstract] [Full Text] [Related]
29. The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis. Krivinka R; Tousek J Antibiot Chemother; 1970; 16():215-21. PubMed ID: 4108889 [No Abstract] [Full Text] [Related]
30. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England. Somner AR; Selkon JB; Walton M; White AB Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922 [No Abstract] [Full Text] [Related]
31. [Mode of action of "tuverculostatics". Consequences for the therapy]. Krebs A Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006 [No Abstract] [Full Text] [Related]
32. [Principles underlying the use of antituberculosis medication in children (author's transl)]. Ollivier A; Besson-Leaud M Sem Hop; 1979 Oct 8-15; 55(33-34):1529-35. PubMed ID: 229564 [TBL] [Abstract][Full Text] [Related]
33. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests]. Tsukamura M Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456 [No Abstract] [Full Text] [Related]
34. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations]. Mamolat AS; Bialik IB Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969 [No Abstract] [Full Text] [Related]
35. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2]. Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936 [No Abstract] [Full Text] [Related]
36. Ethambutol in the retreatment of chronic pulmonary tuberculosis. Lees AW; Tyrrell WF; Smith J; Allan GW Br J Dis Chest; 1970 Apr; 64(2):85-9. PubMed ID: 5432629 [No Abstract] [Full Text] [Related]
37. [Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis]. Naegeli HR Schweiz Med Wochenschr; 1966 Apr; 96(15):495-500. PubMed ID: 4293638 [No Abstract] [Full Text] [Related]
38. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
39. Bacteriology of tuberculosis with special reference to kanamycin and related drugs. Dye WE Ann N Y Acad Sci; 1966 Jun; 132(2):901-4. PubMed ID: 4290030 [No Abstract] [Full Text] [Related]
40. A ten-year clinical experience with Mycobacterium kansasii. Rauscher CR; Kerby G; Ruth WE Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]